Payment overview · 2025
General Payments
$66.28
3 reported records · 2 companies
Healthcare provider profile · identity verified
Andrew D Kim, MD
Allopathic & Osteopathic Physicians|Internal Medicine · MEDFORD, OR · NPI 1376639245
Verified facts
What the public records show
CMS Open Payments records show Andrew D Kim, MD received $66.28 in general payments during 2025 across 3 reported records.
Abbott Laboratories accounted for 66.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 42 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $44.07 | 66.5% | 2 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $22.21 | 33.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $66.28 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $44.07 | 2 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $22.21 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
42 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 876 | 234 |
| Amlodipine Besylate | Amlodipine Besylate | 641 | 175 |
| Losartan Potassium | Losartan Potassium | 571 | 156 |
| Levothyroxine Sodium | Levothyroxine Sodium | 569 | 143 |
| Omeprazole | Omeprazole | 504 | 140 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 427 | 68 |
| Metoprolol Succinate | Metoprolol Succinate | 392 | 104 |
| Lisinopril | Lisinopril | 381 | 102 |
| Gabapentin | Gabapentin | 368 | 94 |
| Trazodone Hcl | Trazodone Hcl | 290 | 66 |
| Oxycodone Hcl | Oxycodone Hcl | 285 | 36 |
| Furosemide | Furosemide | 250 | 71 |
| Tamsulosin Hcl | Tamsulosin Hcl | 226 | 71 |
| Pantoprazole Sodium | Pantoprazole Sodium | 219 | 57 |
| Duloxetine Hcl | Duloxetine Hcl | 216 | 50 |
| Spironolactone | Spironolactone | 199 | 59 |
| Hydrochlorothiazide | Hydrochlorothiazide | 190 | 61 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 187 | 55 |
| Potassium Chloride | Potassium Chloride | 186 | 45 |
| Eliquis | Apixaban | 182 | 47 |
| Metformin Hcl | Metformin Hcl | 176 | 47 |
| Bupropion Xl | Bupropion Hcl | 167 | 37 |
| Tizanidine Hcl | Tizanidine Hcl | 135 | 41 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 132 | 58 |
| Mirtazapine | Mirtazapine | 132 | 39 |
| Clopidogrel | Clopidogrel Bisulfate | 131 | 33 |
| Simvastatin | Simvastatin | 127 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 126 | 32 |
| Metformin Hcl Er | Metformin Hcl | 125 | 35 |
| Allopurinol | Allopurinol | 119 | 28 |
| Carvedilol | Carvedilol | 117 | 36 |
| Diazepam | Diazepam | 116 | 15 |
| Donepezil Hcl | Donepezil Hcl | 116 | 28 |
| Sertraline Hcl | Sertraline Hcl | 113 | 29 |
| Finasteride | Finasteride | 110 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 98 | 28 |
| Ondansetron Odt | Ondansetron | 98 | 31 |
| Jardiance | Empagliflozin | 97 | 24 |
| Clonazepam | Clonazepam | 96 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 94 | 14 |
| Pregabalin | Pregabalin | 90 | 18 |
| Glipizide Er | Glipizide | 88 | 19 |
| Atenolol | Atenolol | 85 | 26 |
| Zolpidem Tartrate | Zolpidem Tartrate | 83 | 23 |
| Escitalopram Oxalate | Escitalopram Oxalate | 82 | 23 |
| Meloxicam | Meloxicam | 81 | 27 |
| Lorazepam | Lorazepam | 80 | 22 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 79 | 13 |
| Alendronate Sodium | Alendronate Sodium | 76 | 27 |
| Famotidine | Famotidine | 76 | 22 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 76 | 16 |
| Terazosin Hcl | Terazosin Hcl | 75 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 74 | 35 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 74 | 22 |
| Baclofen | Baclofen | 73 | 15 |
| Tramadol Hcl | Tramadol Hcl | 71 | 22 |
| Alprazolam | Alprazolam | 68 | 19 |
| Xarelto | Rivaroxaban | 66 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 65 | 11 |
| Morphine Sulfate Er | Morphine Sulfate | 58 | suppressed |
| Valsartan | Valsartan | 57 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 56 | 11 |
| Warfarin Sodium | Warfarin Sodium | 56 | 15 |
| Doxepin Hcl | Doxepin Hcl | 54 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 54 | 14 |
| Nabumetone | Nabumetone | 54 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 53 | suppressed |
| Prednisone | Prednisone | 53 | 28 |
| Buspirone Hcl | Buspirone Hcl | 51 | 16 |
| Bupropion Hcl Sr | Bupropion Hcl | 46 | 12 |
| Ibuprofen | Ibuprofen | 43 | suppressed |
| Lovastatin | Lovastatin | 43 | 14 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 42 | suppressed |
| Ozempic | Semaglutide | 42 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 42 | suppressed |
| Aripiprazole | Aripiprazole | 38 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | suppressed |
| Memantine Hcl | Memantine Hcl | 38 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 38 | suppressed |
| Nystatin | Nystatin | 37 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 36 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 36 | 11 |
| Verapamil Er | Verapamil Hcl | 36 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 35 | 12 |
| Clonidine Hcl | Clonidine Hcl | 34 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 34 | 12 |
| Montelukast Sodium | Montelukast Sodium | 34 | suppressed |
| Mounjaro | Tirzepatide | 34 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 34 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 33 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 32 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 31 | suppressed |
| Ezetimibe | Ezetimibe | 31 | 12 |
| Labetalol Hcl | Labetalol Hcl | 31 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 31 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 31 | suppressed |
| Estradiol | Estradiol | 30 | 12 |
| Eszopiclone | Eszopiclone | 30 | suppressed |
| Methylprednisolone | Methylprednisolone | 30 | 22 |
| Prazosin Hcl | Prazosin Hcl | 30 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 29 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Nitroglycerin | Nitroglycerin | 28 | 19 |
| Pioglitazone Hcl | Pioglitazone Hcl | 28 | suppressed |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Myrbetriq | Mirabegron | 27 | suppressed |
| Risperidone | Risperidone | 27 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 26 | suppressed |
| Synthroid | Levothyroxine Sodium | 26 | suppressed |
| Glipizide | Glipizide | 25 | suppressed |
| Movantik | Naloxegol Oxalate | 25 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 24 | suppressed |
| Trulicity | Dulaglutide | 24 | suppressed |
| Ketoconazole | Ketoconazole | 23 | 11 |
| Verapamil Sr | Verapamil Hcl | 23 | suppressed |
| Calcitriol | Calcitriol | 22 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 22 | 13 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 22 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 22 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 22 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 21 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 21 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 21 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 20 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 20 | suppressed |
| Celecoxib | Celecoxib | 19 | 11 |
| Insulin Aspart Flexpen | Insulin Aspart | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 19 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 19 | suppressed |
| Olanzapine | Olanzapine | 19 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Linzess | Linaclotide | 18 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 18 | suppressed |
| Methadone Hcl | Methadone Hcl | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Latanoprost | Latanoprost | 17 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Cephalexin | Cephalexin | 16 | 11 |
| Loperamide | Loperamide Hcl | 16 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 16 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 16 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 16 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Amoxicillin | Amoxicillin | 15 | 12 |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 15 | suppressed |
| Lactulose | Lactulose | 15 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Buprenorphine | Buprenorphine | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | 11 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Entecavir | Entecavir | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 12 | suppressed |
| Azithromycin | Azithromycin | 12 | suppressed |
| Codeine Sulfate | Codeine Sulfate | 12 | suppressed |
| Emgality Pen | Galcanezumab-Gnlm | 12 | suppressed |
| Epinephrine | Epinephrine | 12 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Progesterone | Progesterone, Micronized | 12 | suppressed |
| Belbuca | Buprenorphine Hcl | 11 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Constulose | Lactulose | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Lacosamide | Lacosamide | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $66.28 · 3 records | Abbott Laboratories | FREESTYLE LIBRE 3, Wegovy | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error